The electron transport chain (ETC) stands as a fundamental process in biology, acting as a series of protein complexes that orchestrate redox reactions. This intricate system’s primary purpose is to establish an electrochemical gradient, a crucial step that ultimately drives the creation of ATP. This entire process, known as oxidative phosphorylation, is essential for life and occurs within the mitochondria for cellular respiration and in chloroplasts during photosynthesis. In cellular respiration, the ETC harnesses energy from the breakdown of organic molecules. Conversely, in photosynthesis, it captures light energy to build carbohydrates.
The Basics of Energy Production
Aerobic cellular respiration, the process by which cells generate energy, is composed of three interconnected stages: glycolysis, the citric acid cycle (Krebs cycle), and oxidative phosphorylation. Glycolysis initiates the breakdown of glucose into two pyruvate molecules, yielding a small amount of ATP and NADH. Subsequently, each pyruvate undergoes oxidation to form acetyl CoA, along with additional NADH and carbon dioxide (CO2). Acetyl CoA then enters the citric acid cycle, a sequence of chemical reactions that further produces CO2, NADH, FADH2, and ATP. The culmination of these initial stages leads to oxidative phosphorylation, where the accumulated NADH and FADH2 are utilized to produce water and a substantial amount of ATP.
Oxidative phosphorylation itself is a two-part process encompassing the electron transport chain (ETC) and chemiosmosis. The ETC is a network of proteins embedded within the inner mitochondrial membrane, alongside organic molecules. Electrons are passed through this chain in a series of redox reactions, releasing energy at each step. This released energy is not directly used to make ATP but instead is cleverly employed to pump protons across the inner mitochondrial membrane, creating a proton gradient. This gradient then becomes the driving force for chemiosmosis. Chemiosmosis is the process where the potential energy stored in the proton gradient is harnessed by ATP synthase to generate a significant quantity of ATP.
Photosynthesis, the process used by plants and other organisms to convert light energy into chemical energy, also utilizes an electron transport chain. In the light-dependent reactions of photosynthesis, light energy and water are used to produce ATP, NADPH, and oxygen (O2). Just like in cellular respiration, a proton gradient, generated by an electron transport chain, is crucial for ATP production. The ATP and NADPH generated in the light-dependent reactions are then used in the light-independent reactions (Calvin cycle) to synthesize sugars.
The Electron Transport Chain at the Cellular Level
Within the electron transport chain (ETC), electrons navigate a series of protein complexes, each exhibiting an increasing reduction potential. This stepwise transfer of electrons is accompanied by the release of energy at each transfer point. A significant portion of this released energy is dissipated as heat, contributing to maintaining body temperature. However, a crucial part of this energy is harnessed to actively pump hydrogen ions (H+) from the mitochondrial matrix to the intermembrane space. This directional pumping establishes a proton gradient across the inner mitochondrial membrane. This gradient is characterized by a higher concentration of protons (and thus increased acidity) in the intermembrane space and a corresponding electrical difference, with a positive charge on the outside and a negative charge on the matrix side of the membrane.
The protein complexes that make up the ETC are arranged in a specific sequence: Complex I, Complex II, Coenzyme Q, Complex III, Cytochrome C, and Complex IV.
-
Complex II, also known as succinate dehydrogenase, serves as an alternative entry point for electrons into the ETC. It accepts electrons from succinate, an intermediate molecule in the citric acid cycle. When succinate is oxidized to fumarate, two electrons are transferred to FAD within Complex II. FAD then passes these electrons to iron-sulfur (Fe-S) clusters and subsequently to coenzyme Q, similar to how Complex I functions. However, a key difference is that Complex II does not pump protons across the mitochondrial membrane during electron transfer. Consequently, electron flow through Complex II results in the production of less ATP compared to Complex I pathways.[5][6]
- Reaction: Succinate + FAD → Fumarate + 2 H+(matrix) + FADH2
- Reaction: FADH2 + CoQ → FAD + CoQH2
-
Coenzyme Q, also known as ubiquinone (CoQ), is a mobile electron carrier composed of a quinone group and a hydrophobic tail. Its primary role is to transport electrons from both Complex I and Complex II to Complex III. Coenzyme Q undergoes a cyclical reduction and oxidation process known as the Q cycle, transitioning through semiquinone (partially reduced, radical form CoQH–) and ubiquinol (fully reduced CoQH2) states. The detailed mechanism of the Q cycle is further explained under Complex III.
ATP synthase, also called Complex V, is the remarkable enzyme that directly utilizes the proton gradient generated by the ETC to synthesize ATP. ATP synthase is composed of two main subunits: F0 and F1, which function together as a rotary motor. The F0 subunit is hydrophobic and embedded within the inner mitochondrial membrane, forming a channel for protons to flow across the membrane. As H+ ions move down their electrochemical gradient from the intermembrane space back into the mitochondrial matrix through F0, they cause the F0 subunit to rotate. This rotation mechanically alters the conformation of the hydrophilic F1 subunit, which protrudes into the mitochondrial matrix. These conformational changes in the F1 subunits provide the energy needed to catalyze the synthesis of ATP from ADP and inorganic phosphate (Pi). It is estimated that for every four protons that pass through ATP synthase, one molecule of ATP is produced. Interestingly, ATP synthase can also operate in reverse. Under certain conditions, it can use the energy from ATP hydrolysis to pump protons against their gradient, contributing to the maintenance of the proton gradient, as observed in some bacteria.[15][16][17]
The Electron Transport Chain at the Molecular Level
Nicotinamide adenine dinucleotide (NAD) plays a critical role as an electron carrier in cellular metabolism, existing in two forms: NAD+ (oxidized) and NADH (reduced). NAD+ and NADH are dinucleotides, linked by phosphate groups, with one nucleoside containing an adenine base and the other a nicotinamide base. In metabolic redox reactions, NAD+ acts as an electron acceptor, becoming reduced to NADH, as depicted in Reaction 1.
- Reaction 1: RH2 + NAD+ → R + H+ + NADH
In this reaction, RH2 represents a reactant molecule, such as a sugar molecule, that is being oxidized.
NADH generated from glycolysis and the citric acid cycle enters the ETC at Complex I. As electrons are transferred from NADH through the ETC to oxygen, protons are pumped across the inner mitochondrial membrane at Complexes I, III, and IV. For each NADH molecule oxidized, a total of approximately 10 H+ ions are translocated (4 from Complex I, 4 from Complex III, and 2 from Complex IV). Given that ATP synthase requires approximately 4 H+ ions to synthesize 1 ATP molecule, the oxidation of one NADH molecule theoretically yields about 2.5 ATP molecules (some sources round this value up to 3). When NADH is oxidized in Complex I, it is converted back to NAD+, releasing a proton and two electrons, as shown in Reaction 2.
- Reaction 2: NADH → H+ + NAD+ + 2 e–
Flavin adenine dinucleotide (FAD) is another crucial redox cofactor involved in the ETC. FAD exists in four redox states, with the three primary forms being FAD (quinone, fully oxidized), FADH– (semiquinone, partially reduced), and FADH2 (hydroquinone, fully reduced). FAD is structurally similar to NAD, composed of an adenine nucleotide and a flavin mononucleotide (FMN) linked by phosphate groups. FMN is derived in part from vitamin B2 (riboflavin). A key structural difference is that FAD contains a highly stable aromatic ring, while FADH2 does not. When FADH2 is oxidized back to FAD, the aromatic ring is reformed, releasing energy (Reaction 3). This transition makes FAD a potent oxidizing agent, exhibiting an even more positive reduction potential than NAD+. FADH2 enters the ETC at Complex II. Electron transport from FADH2 through the ETC results in the translocation of fewer protons across the membrane compared to NADH oxidation (approximately 6 H+ ions: 4 from Complex III and 2 from Complex IV). Consequently, the oxidation of one FADH2 molecule yields approximately 1.5 ATP molecules (some sources round up to 2).[18]
- Reaction 3: FADH2 → FAD + 2 H+ + 2 e–
Beyond its role in the ETC, FAD also participates in various other metabolic pathways, including DNA repair (MTHF repair of UV damage), fatty acid beta-oxidation (acyl-CoA dehydrogenase), and the synthesis of other essential coenzymes (CoA, CoQ, heme).
Clinical Significance of the Electron Transport Chain
The electron transport chain’s critical role in energy production makes it a target for various toxins and drugs, highlighting its clinical significance.
Uncoupling Agents
Uncoupling agents are compounds that disrupt the tight coupling between the electron transport chain and ATP synthesis by ATP synthase. These agents effectively dissociate the proton gradient from the ATP-generating machinery. Many uncoupling agents are lipophilic molecules that can insert into the inner mitochondrial membrane and increase its permeability to protons. This increased proton permeability allows protons to leak back across the membrane into the mitochondrial matrix without passing through ATP synthase. This “proton leak” dissipates the electrochemical gradient, reducing or eliminating ATP production.
As ATP production decreases, the cell senses an energy deficit and attempts to compensate by increasing the rate of electron transport. The ETC becomes overactive, trying to pump more protons to restore the gradient, but the uncoupling agent prevents the gradient from being effectively used to make ATP. Since electron transport and proton pumping are exothermic processes, this overactivity leads to increased heat generation. This can result in a rise in body temperature, potentially leading to hyperthermia. Furthermore, with reduced ATP availability, cells may shift to anaerobic metabolism, such as fermentation, to generate ATP. This can lead to the accumulation of lactic acid and potentially cause type B lactic acidosis in affected individuals.[19]
- Aspirin (Salicylic Acid): In high doses, aspirin can act as an uncoupling agent.
- Thermogenin: This is a natural uncoupling protein found in brown adipose tissue, playing a role in non-shivering thermogenesis (heat production).
Oxidative Phosphorylation Inhibitors
Oxidative phosphorylation inhibitors are substances that directly block specific components of the electron transport chain or ATP synthase, thereby halting ATP production. Several potent poisons act as ETC inhibitors, including rotenone, carboxin, antimycin A, cyanide, carbon monoxide (CO), sodium azide, and oligomycin.
- Rotenone: Inhibits Complex I by blocking the coenzyme Q binding site.
- Carboxin: Inhibits Complex II, also at the coenzyme Q binding site.
- Carboxin, previously used as a fungicide, is now less common due to the availability of more effective broad-spectrum agents. Like rotenone, it disrupts ubiquinone function at its binding site on Complex II.
- Doxorubicin: An anticancer drug that may theoretically interfere with coenzyme Q function.
- Antimycin A: Inhibits Complex III (cytochrome c reductase) by binding to the Qi binding site.
- Antimycin A, used as a piscicide, prevents ubiquinone from binding and accepting electrons at Complex III, thus blocking the Q cycle and electron flow.
- Carbon Monoxide (CO): Inhibits Complex IV (cytochrome c oxidase) by binding to the heme iron.
- Cyanide (CN): Also inhibits Complex IV (cytochrome c oxidase), similar to carbon monoxide.
- Cyanide poisoning results in cellular hypoxia due to the ETC blockage, leading to symptoms similar to oxygen deprivation. However, unlike typical hypoxia, cyanide poisoning is not responsive to supplemental oxygen. A characteristic sign of cyanide poisoning can be the odor of bitter almonds on the breath. Common sources of cyanide exposure include smoke inhalation from fires (especially involving furniture and rugs), jewelry cleaning solutions, plastic and rubber manufacturing, and, less commonly, iatrogenic exposure from nitroprusside administration or ingestion of certain fruit seeds (apricots, peaches, apples).
- Treatment for cyanide poisoning can involve nitrites, which induce methemoglobinemia. Methemoglobin (Fe3+ form of hemoglobin) binds cyanide, preventing it from inhibiting cytochrome c oxidase. However, methemoglobin reduces oxygen-carrying capacity, so further treatment with methylene blue is needed to convert methemoglobin back to functional hemoglobin (Fe2+). Other treatments include hydroxocobalamin (a form of vitamin B12) and thiosulfate, although thiosulfate is often used in combination with nitrites due to its slower action.[32]
- Oligomycin: Inhibits ATP synthase (Complex V) by binding to the F0 subunit and blocking the proton channel. [23][24]
Review Questions
Figure
Electron Transport Chain graphic. Depicts the Inter-membrane space, inner membrane, and matrix regions of the mitochondria, illustrating the process of electron transport and ATP synthesis. Illustration by Emma Gregory
References
1.Lencina AM, Franza T, Sullivan MJ, Ulett GC, Ipe DS, Gaudu P, Gennis RB, Schurig-Briccio LA. Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target. mBio. 2018 Jul 03;9(4) [PMC free article: PMC6030563] [PubMed: 29970468]
2.Hirst J. Towards the molecular mechanism of respiratory complex I. Biochem J. 2009 Dec 23;425(2):327-39. [PubMed: 20025615]
3.Sazanov LA, Hinchliffe P. Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus. Science. 2006 Mar 10;311(5766):1430-6. [PubMed: 16469879]
4.Hirst J. Energy transduction by respiratory complex I–an evaluation of current knowledge. Biochem Soc Trans. 2005 Jun;33(Pt 3):525-9. [PubMed: 15916556]
5.Yankovskaya V, Horsefield R, Törnroth S, Luna-Chavez C, Miyoshi H, Léger C, Byrne B, Cecchini G, Iwata S. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science. 2003 Jan 31;299(5607):700-4. [PubMed: 12560550]
6.Horsefield R, Iwata S, Byrne B. Complex II from a structural perspective. Curr Protein Pept Sci. 2004 Apr;5(2):107-18. [PubMed: 15078221]
7.Geertman JM, van Maris AJ, van Dijken JP, Pronk JT. Physiological and genetic engineering of cytosolic redox metabolism in Saccharomyces cerevisiae for improved glycerol production. Metab Eng. 2006 Nov;8(6):532-42. [PubMed: 16891140]
8.Thorpe C, Kim JJ. Structure and mechanism of action of the acyl-CoA dehydrogenases. FASEB J. 1995 Jun;9(9):718-25. [PubMed: 7601336]
9.Sun C, Benlekbir S, Venkatakrishnan P, Wang Y, Hong S, Hosler J, Tajkhorshid E, Rubinstein JL, Gennis RB. Structure of the alternative complex III in a supercomplex with cytochrome oxidase. Nature. 2018 May;557(7703):123-126. [PMC free article: PMC6004266] [PubMed: 29695868]
10.Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S, Jap BK. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science. 1998 Jul 03;281(5373):64-71. [PubMed: 9651245]
11.Trumpower BL. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J Biol Chem. 1990 Jul 15;265(20):11409-12. [PubMed: 2164001]
12.Hunte C, Palsdottir H, Trumpower BL. Protonmotive pathways and mechanisms in the cytochrome bc1 complex. FEBS Lett. 2003 Jun 12;545(1):39-46. [PubMed: 12788490]
13.Calhoun MW, Thomas JW, Gennis RB. The cytochrome oxidase superfamily of redox-driven proton pumps. Trends Biochem Sci. 1994 Aug;19(8):325-30. [PubMed: 7940677]
14.Schmidt-Rohr K. Oxygen Is the High-Energy Molecule Powering Complex Multicellular Life: Fundamental Corrections to Traditional Bioenergetics. ACS Omega. 2020 Feb 11;5(5):2221-2233. [PMC free article: PMC7016920] [PubMed: 32064383]
15.Lovero D, Giordano L, Marsano RM, Sanchez-Martinez A, Boukhatmi H, Drechsler M, Oliva M, Whitworth AJ, Porcelli D, Caggese C. Characterization of Drosophila ATPsynC mutants as a new model of mitochondrial ATP synthase disorders. PLoS One. 2018;13(8):e0201811. [PMC free article: PMC6086398] [PubMed: 30096161]
16.Okuno D, Iino R, Noji H. Rotation and structure of FoF1-ATP synthase. J Biochem. 2011 Jun;149(6):655-64. [PubMed: 21524994]
17.Junge W, Nelson N. ATP synthase. Annu Rev Biochem. 2015;84:631-57. [PubMed: 25839341]
18.Hinkle PC. P/O ratios of mitochondrial oxidative phosphorylation. Biochim Biophys Acta. 2005 Jan 07;1706(1-2):1-11. [PubMed: 15620362]
19.Barrett MA, Zheng S, Roshankar G, Alsop RJ, Belanger RK, Huynh C, Kučerka N, Rheinstädter MC. Interaction of aspirin (acetylsalicylic acid) with lipid membranes. PLoS One. 2012;7(4):e34357. [PMC free article: PMC3328472] [PubMed: 22529913]
20.Warrick BJ, King A, Smolinske S, Thomas R, Aaron C. A 29-year analysis of acute peak salicylate concentrations in fatalities reported to United States poison centers. Clin Toxicol (Phila). 2018 Sep;56(9):846-851. [PubMed: 29431532]
21.Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids. 2005 Jul;73(1):9-15. [PubMed: 15936182]
22.Enerbäck S. The origins of brown adipose tissue. N Engl J Med. 2009 May 07;360(19):2021-3. [PubMed: 19420373]
23.Zhou W, Faraldo-Gómez JD. Membrane plasticity facilitates recognition of the inhibitor oligomycin by the mitochondrial ATP synthase rotor. Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):789-796. [PMC free article: PMC6176861] [PubMed: 29630891]
24.Kamalian L, Douglas O, Jolly CE, Snoeys J, Simic D, Monshouwer M, Williams DP, Kevin Park B, Chadwick AE. The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity. Toxicol In Vitro. 2018 Dec;53:136-147. [PubMed: 30096366]
25.Wood DM, Alsahaf H, Streete P, Dargan PI, Jones AL. Fatality after deliberate ingestion of the pesticide rotenone: a case report. Crit Care. 2005 Jun;9(3):R280-4. [PMC free article: PMC1175899] [PubMed: 15987402]
26.Lupescu A, Jilani K, Zbidah M, Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology. 2012 Oct 28;300(3):132-7. [PubMed: 22727881]
27.Wallace KB. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol. 2003 Sep;93(3):105-15. [PubMed: 12969434]
28.Weaver LK. Clinical practice. Carbon monoxide poisoning. N Engl J Med. 2009 Mar 19;360(12):1217-25. [PubMed: 19297574]
29.Sato K, Tamaki K, Hattori H, Moore CM, Tsutsumi H, Okajima H, Katsumata Y. Determination of total hemoglobin in forensic blood samples with special reference to carboxyhemoglobin analysis. Forensic Sci Int. 1990 Nov;48(1):89-96. [PubMed: 2279722]
30.Barker SJ, Tremper KK. The effect of carbon monoxide inhalation on pulse oximetry and transcutaneous PO2. Anesthesiology. 1987 May;66(5):677-9. [PubMed: 3578881]
31.Raub JA, Mathieu-Nolf M, Hampson NB, Thom SR. Carbon monoxide poisoning–a public health perspective. Toxicology. 2000 Apr 07;145(1):1-14. [PubMed: 10771127]
32.Jensen P, Wilson MT, Aasa R, Malmström BG. Cyanide inhibition of cytochrome c oxidase. A rapid-freeze e.p.r. investigation. Biochem J. 1984 Dec 15;224(3):829-37. [PMC free article: PMC1144519] [PubMed: 6098268]
33.Shchepina LA, Pletjushkina OY, Avetisyan AV, Bakeeva LE, Fetisova EK, Izyumov DS, Saprunova VB, Vyssokikh MY, Chernyak BV, Skulachev VP. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene. 2002 Nov 21;21(53):8149-57. [PubMed: 12444550]
Disclosure: Maria Ahmad declares no relevant financial relationships with ineligible companies.
Disclosure: Adam Wolberg declares no relevant financial relationships with ineligible companies.
Disclosure: Chadi Kahwaji declares no relevant financial relationships with ineligible companies.
